|
IFNGR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.037400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.930400E-02 |
| Normal-vs-Stage2 |
1.434380E-01 |
| Normal-vs-Stage3 |
5.705000E-01 |
| Normal-vs-Stage4 |
1.585230E-01 |
| Stage1-vs-Stage2 |
2.483100E-03 |
| Stage1-vs-Stage3 |
2.652800E-01 |
| Stage1-vs-Stage4 |
9.083000E-01 |
| Stage2-vs-Stage3 |
6.225900E-02 |
| Stage2-vs-Stage4 |
1.387730E-02 |
| Stage3-vs-Stage4 |
3.978600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.512300E-02 |
| Normal-vs-AfricanAmerican |
6.040600E-01 |
| Normal-vs-Asian |
2.079800E-01 |
| Caucasian-vs-AfricanAmerican |
5.673600E-01 |
| Caucasian-vs-Asian |
8.939600E-01 |
| AfricanAmerican-vs-Asian |
6.594800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.699800E-01 |
| Normal-vs-Female |
1.086580E-01 |
| Male-vs-Female |
1.253420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.184400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.078000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.545800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.275000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.654440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.219700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.838000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.686200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.172600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.874400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.396400E-01 |
| Classical-VS-Follicular |
3.33066907387547E-16 |
| Classical-VS-Other |
2.726000E-01 |
| Classical-VS-Normal |
7.875900E-03 |
| Tall-VS-Follicular |
1.46640000031617E-07 |
| Tall-VS-Other |
2.372400E-01 |
| Tall-VS-Normal |
2.325500E-02 |
| Follicular-VS-Other |
1.096040E-01 |
| Follicular-VS-Normal |
2.422000E-04 |
| Other-VS-Normal |
9.838400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.632600E-01 |
| Normal-vs-N1 |
3.743900E-02 |
| N0-vs-N1 |
1.196570E-03 |
|
|
